Health
Ava Announces Launch of First Clinical Trial Evaluating Effectiveness of Its Fertility Tracking Sensor Bracelet in Real-time, Pre-Symptomatic Detection of COVID-19 – PRNewswire
/PRNewswire/ — Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind……
ZURICH, March 23, 2021 /PRNewswire/ — Ava, a digital healthcare company that focuses on women’s reproductive health, announced today it will be launching the first study of its kind to test whether a wearable device can detect a COVID-19 infection in real-time and alert people to get tested or self-isolate prior to showing symptoms.
While other studies to date (including the COVI-GAPP study Ava announced in April 2020
) have examined the feasibility of using machine learning and wearable devices…
-
Noosa News24 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General11 hours agoAustralia welcomes Gaza peace progress, hostage release
-
Business14 hours agoBell Potter names the best ASX shares to buy in October
-
Noosa News18 hours ago28 years later: Grim reality for single house hunters revealed